The presentation details are as follows: Rodman & Renshaw Annual Global Investment Conference Wednesday, November 12, 2008, 10:20 a.m. ET New York, NY Lazard Capital Markets Healthcare Conference Wednesday, November 19, 2008, 11:30 a.m. ET New York, NY 20th Annual Piper Jaffray Health Care Conference Tuesday, December 2, 2008, 4:00 p.m. ET New York, NY
Interested parties may access live audio webcasts of the presentations from the investor section of the VIA website, http://www.viapharmaceuticals.com. Replays of the presentations will be archived on the VIA website for at least one week following each presentation.
About VIA Pharmaceuticals, Inc.
VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. VIA is building a pipeline of small-molecule drugs that target a significant unmet medical need: reducing inflammation in the blood vessel wall, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke. The company's lead drug candidate, VIA-2291, is in multiple Phase 2 clinical studies in patients with cardiovascular disease. For more information, visit: http://www.viapharmaceuticals.com.
SOURCE VIA Pharmaceuticals, Inc.